by molly | Oct 15, 2024 | Media
RxCelerate & Babraham Research Campus host panel on “Prioritising mental health in the workplace” Cambridge, UK 15th October 2024, 9AM GMT World Mental Health Day was on the 10th of October, and it is a day for mental health education, awareness and...
by hafeez | Sep 18, 2024 | Media
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease Cambridge, UK Wednesday 18th September 2024, 9AM GMT Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke...
by molly | Jul 9, 2024 | Media
RxCelerate’s new company values, co-created by our people Cambridge, UK, July 2024 We are pleased to share our new company values – to support us as we continue building and developing as a people-first organisation. These values were shaped through a...
by molly | Apr 24, 2024 | Media
New Drosophila screening lab further expands RxCelerate’s drug discovery and development capabilities Cambridge, UK Wednesday 24th April 2024, 9AM GMT RxCelerate is excited to launch our new fly screening service, further expanding the bespoke and flexible drug...
by admin | Nov 22, 2022 | Media
RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service Cambridge, UK and Cambridge, MA Tuesday 22nd November 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today announced...
by admin | Jul 19, 2022 | Media
RxCelerate launch RxNfinity™: a next-generation machine learning-enabled small molecule discovery platform Cambridge, UK and Cambridge, MA – Tuesday 19th July 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today...